Latest Aspirin Stories
Adding vorapaxar, an investigational platelet blocker, to standard antiplatelet therapy significantly reduces the risk of recurrent cardiovascular events in patients with known atherosclerosis, a hardening and narrowing of the arteries.
Two new studies published this week have found that taking aspirin every day may significantly reduce the risk of many cancers and prevent tumors from spreading.
The humble aspirin may soon have a new role. Scientists from The City College of New York have developed a new aspirin compound that has great promise to be not only an extremely potent cancer-fighter, but even safer than the classic medicine cabinet staple.
Older women whose diets include a substantial amount of trans fats are more likely than their counterparts to suffer an ischemic stroke.
New research shows an increased risk of ischemic stroke in postmenopausal women who consume higher amounts of trans fatty acids, commonly found in baked goods, fried foods, and packaged products.
Scientists at Emory University School of Medicine have identified a new group of compounds that may protect brain cells from inflammation linked to seizures and neurodegenerative diseases.
Following a total joint replacement, anticoagulation (blood thinning) drugs can prevent Deep Vein Thrombosis (DVT), a blood clot deep within the extremities, or a pulmonary embolism (PE), a complication that causes a blood clot to move to the lungs.
In the largest and longest head-to-head comparison of two anti-clotting medications, warfarin and aspirin were similar in preventing deaths and strokes in heart failure patients with normal heart rhythm, according to late-breaking research presented at the American Stroke Association’s International Stroke Conference 2012.
- Large; stout; burly.
More Images (1 images) »